Please use this identifier to cite or link to this item:
http://hdl.handle.net/11452/22728
Title: | Nonbronchoscopic bronchoalveolar lavage for diagnosing ventilator-associated pneumonia in newborns |
Authors: | Uludağ Üniversitesi/Tıp Fakültesi/Pediatri Anabilim Dalı. Uludağ Üniversitesi/Tıp Fakültesi/Enfeksiyon Hastalıkları ve Mikrobiyoloji Anabilim Dalı. Köksal, Nilgün Hacımustafaoğlu, Mustafa Çelebi, Solmaz Özakın, Cüneyt 7003323615 6602154166 7006095295 57200678942 |
Keywords: | Pediatrics Ventilator-associated pneumonia Sepsis Premature Mechanical ventilation Newborn Nonbronchoscopic bronchoalveolar lavag Fluid Accuracy Risk-factors Nosocomial pneumonia Protected specimen brush |
Issue Date: | 2006 |
Publisher: | Türk Milli Pediatri Derneği |
Citation: | Köksal, N. vd. (2006). ''Nonbronchoscopic bronchoalveolar lavage for diagnosing ventilator-associated pneumonia in newborns''. Turkish Journal of Pediatrics, 48(3), 213-220. |
Abstract: | The appropriate treatment of ventilator-associated pneumonia (VAP) must be based on accurate diagnosis, which can be done by microbiological examination of the samples obtained from the respiratory tract by nonbronchoscopic bronchoalveolar lavages (NB-BAL). This study was designed to determine the effectiveness of NB-BAL in diagnosing VAP in newborns. Two hundred and seven NB-BAL samples were obtained from 145 intubated neonates for microbiologic and cytologic evaluation of the distal air-way. The NB-BAL samples were processed for microscopic quantification of the polymorphonuclear cells (PMN) containing intracellular bacteria (ICB) and quantitative culture (positive threshold, 10(5) cfu/ml). VAP was defined as a new, progressive, or persistent (>24 hrs) infiltrate on the chest radiograph, with two or more of the following criteria: a) macroscopically purulent tracheal secretions, b) fever or hypothermia, c) leukocytosis or leukopenia, and d) worsening of respiratory status with a Pa O-2/F IO2 ratio of <240. Colonization was defined as mechanical ventilation for more than seven days, no signs of infection, and isolation of the same bacteria species in two previously obtained NB-BAL samples. Of the 145 neonates, 40 (27.5%) were infected and 12 (8.3%) were colonized. Forty-four patients (30%) developed VAP according to diagnostic categories based on clinical and radiologic criteria. Forty newborns with VAP (90%) had positive NB-BAL culture. The sensitivity, specificity, and positive and negative predictive values of NB-BAL fluid culture for VAP diagnosis were 90%, 90%, 70%, and 97%, respectively. The percentage of ICB was significantly higher in newborns with VAP. The presence of ICB in 2% or more on Giemsa-stained smears corresponded to a sensitivity of 94%, specificity of 83%, positive predictive value of 94%, and negative predictive value of 83%. The sensitivity and specificity of combination of ICB and NB-BAL quantitative culture in diagnostic samples were 94% and 90%, respectively. The positive and negative predictive values were 71% and 98%. In our study, the presence of leukocytes in the NB-BAL fluid smear of infants with VAP was higher than that of the colonized babies (84%, 26%). This difference was statistically significant (p<0.0001). The sensitivity and specificity of PMNs in NB-BAL fluid for the diagnosis were 86% and 75%, respectively, and the positive and negative predictive values were 89% and 69%. We conclude that NB-BAL lavage is well tolerated and clinically useful in mechanically ventilated newborns. These results suggest that NB-BAL fluid microscopic examination and cultures can offer a sensitive and specific means to diagnose VAP in newborns and may provide relevant information about the causative pathogens. |
URI: | https://www.turkishjournalpediatrics.org/uploads/pdf_TJP_339.pdf http://hdl.handle.net/11452/22728 |
ISSN: | 0041-4301 |
Appears in Collections: | Scopus TrDizin Web of Science |
Files in This Item:
File | Description | Size | Format | |
---|---|---|---|---|
Köksal_vd_2006.pdf | 158.85 kB | Adobe PDF | View/Open |
This item is licensed under a Creative Commons License